1b: Anti-emetics
|
Simple drugs used in a subcutaneous infusion over 24 hours in palliative care (tables 1a to 1f) Diluent: water for injection unless stated and make up to 17 ml in 20 ml syringe or 22 ml in 30 ml syringe using a BD Bodyguard T pump or 24 ml or 48 ml in a 50 ml syringe in a non-ambulatory pump |
||
|
Single agents |
Uses and typical dose ranges |
Comments |
|
Table 1b: Anti-emetics |
||
|
CYCLIZINE 50 mg in 1 ml |
Nausea and vomiting (bowel obstruction or intracranial disease) Dose: 50 mg to 150 mg over 24 hours |
Anticholinergic, reduces peristalsis Can cause redness, irritation at site Incompatible with 0.9% saline, always use water for injection |
|
HALOPERIDOL 5 mg in 1 ml 10 mg in 2 ml |
Opioid or metabolic induced nausea, delirium Dose: 1 mg to 5 mg over 24 hours |
Long half life, can also be given as a once daily SC injection Extrapyramidal side effects |
|
LEVOMEPROMAZINE 25 mg in 1 ml |
Complex nausea, terminal delirium / agitation Dose: 5 mg to 15 mg over 24 hours – anti emetic Dose: 25 mg to 100 mg over 24 hours - sedative |
Protect from light, exposure can cause purple /yellow discolouration, discard if this occurs Lowers blood pressure Long half life: can be given as a once or twice daily SC injection Second line sedative if midazolam ineffective Refer to levomepromazine guideline |
|
METOCLOPRAMIDE 10 mg in 2 ml |
Nausea and vomiting (peristaltic failure, gastric stasis / outlet obstruction, opioid) Dose: 20 mg to 60 mg over 24 hours |
Prokinetic Avoid if complete bowel obstruction Worsens colic: use with caution Possible risk of extrapyramidal side effects |